marketcaparena
Search

    BRVE

    Braveheart Bio, Inc.

    Company overview

    Market capitalization
    $1.90B
    Employees
    —
    Latest publication
    2026-09-29

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Research Development11,125,000USD
    Total Operating Expenses15,882,000USD
    Net Income-14,988,000USD
    SourceDisclosurePreliminary

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Total Assets126,956,000USD
    Cash And Equivalents122,831,000USD
    Total Current Assets123,445,000USD
    Other Current Assets614,000USD
    Other Non Current Assets70,000USD
    Total Liabilities9,342,000USD
    Total Current Liabilities9,058,000USD
    Other Current Liabilities6,012,000USD
    Other Non Current Liabilities86,000USD
    Total Stockholder Equity-95,906,000USD
    Total Equity Including Noncontrolling Interest117,614,000USD
    Property Plant Equipment Net630,000USD
    Accounts Payable2,669,000USD
    Short Term Debt377,000USD
    Common Stock1,000USD
    Retained Earnings-95,907,000USD
    SourceDisclosureDeterministicFinal

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation5,000USD
    Stock Based Compensation2,846,000USD
    Change To Liabilities4,848,000USD
    Change In Working Capital474,000USD
    Operating Cash Flow-22,136,000USD
    Capital Expenditures-28,000USD
    Unclassified Investing Cash Flow-3,000,000USD
    Investing Cash Flow-3,028,000USD
    Financing Cash Flow58,834,000USD
    Change In Cash33,670,000USD
    End Cash Flow122,831,000USD
    SourceDisclosureDeterministicFinal

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.